Meeting
2021 ASCO Annual Meeting
Early results of intratumoral INT230-6 alone or in combination with ipilimumab in subjects with advanced sarcomas.
Authors
Matthew Ingham
Columbia University Irving Medical Center, New York, NY
Matthew Ingham , James S. Hu , Giles Francis Whalen , Jacob Stephen Thomas , Anthony B. El-Khoueiry , Diana L. Hanna , Anthony J. Olszanski , Christian Frederick Meyer , Nilofer Saba Azad , Syed Mahmood , Lewis H. Bender , Ian B. Walters , Albiruni Ryan Abdul Razak , Lillian L. Siu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Soft Tissue Tumors
Clinical Trial Registration Number
03058289
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 11557)
DOI
10.1200/JCO.2021.39.15_suppl.11557
Abstract #
11557
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: An AGEO European Cohort.
First Author: Lorenzo Pilla
Poster
2024 ASCO Annual Meeting
High dose bolus (HDB) interleukin-2 (IL2) and concurrent low dose ipilimumab followed sequentially by nivolumab in patients with advanced melanoma after failure of anti-PD1-based immunotherapy and BRAF-MEK inhibition.
First Author: Ahmad A. Tarhini
Poster
2024 ASCO Genitourinary Cancers Symposium
Clinical efficacy of lurbinectedin in metastatic neuroendocrine carcinomas of the genitourinary tract: Multi-institutional real-world experience.
First Author: Mohammad Jad Moussa
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Impact of time-of-day on nivolumab monotherapy infusion in patients with metastatic gastric cancer.
First Author: Yasunobu Ishizuka